Wednesday, September 9, 2026
spot_img

Nestlé announces the retirement of Sanjay Bahadur

[Ad hoc announcement pursuant to Art. 53 LR]

This press release is also available in Français (pdf) and Deutsch (pdf)

………….

Nestlé announces the retirement of Sanjay Bahadur

Vevey, November 20, 2025

Sanjay Bahadur, Executive Vice President and Head of Group Strategy and Business Development, will take a well-deserved retirement at the end of December 2025 after a distinguished career of more than 40 years at Nestlé. He has held various roles across India, Switzerland, Hong Kong, Türkiye and China during his tenure. In his current position, Sanjay Bahadur was responsible for portfolio management, the identification and execution of M&A transactions, as well as venture funds, external partnerships and licensing agreements. 

Philipp Navratil, CEO of NestlĂ©, commented: “On behalf of everyone at the company, I would like to extend a heartfelt thanks to Sanjay for his many contributions to NestlĂ©. He consistently demonstrated uncompromising integrity and a humble approach to leadership, fostering trust and collaboration across the organization. We wish him all the best for this next chapter.”

Following Sanjay Bahadur’s retirement, the M&A function will report to CFO Anna Manz.


Contacts:

Media:
Christoph Meier  Tel.: +41 21 924 2200
[email protected]

Investors:
David Hancock  Tel.: +41 21 924 3509
[email protected]

Powered by SlickText.com

Hot this week

Transaction in Own Shares

ICG Enterprise Trust plc (the “Company”) 9 September...

NBPE Announces Transaction in Own Shares

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION...

Total Voting Rights and Transaction in Own Shares

9 September 2026 ICG plc (the “Company”) ...

Pharming Group to participate in September investor conferences

Leiden, the Netherlands, September 9, 2026: Pharming Group N.V. (“Pharming”)...

Topics

Transaction in Own Shares

ICG Enterprise Trust plc (the “Company”) 9 September...

NBPE Announces Transaction in Own Shares

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION...

Total Voting Rights and Transaction in Own Shares

9 September 2026 ICG plc (the “Company”) ...

Pharming Group to participate in September investor conferences

Leiden, the Netherlands, September 9, 2026: Pharming Group N.V. (“Pharming”)...

GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology

Simple, reliable and scalable blood-based testing could identify patients...
spot_img

Related Articles

Popular Categories

spot_img